Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus
Introduction
Gestational diabetes mellitus (GDM) is the most frequent metabolic disorder in pregnancy, affecting 1–10% of all pregnancies (Beischer et al., 1996 and Gabbe, 1986). Although most of the women with GDM return to normal glucose tolerance after delivery, they still have significantly increased risk of developing diabetes later in life (Kim et al., 2002). GDM is considered a prediabetic state, therefore it may display many abnormalities that possibly appear in the very early stages of type 2 diabetes mellitus (T2DM) (Pendegrass et al., 1995). In addition to mechanisms similar to patients with T2DM (Friedman et al., 1999 and Catalano et al., 2002), the etiopathogenesis of GDM includes the combination of the disturbed endocrine function of adipose tissue and placenta (Coughlan et al., 2001, Cseh et al., 2002, Kirwan et al., 2002, Radaelli et al., 2003, Ranheim et al., 2004 and Meller et al., 2006), and the systemic hormonal changes affecting insulin sensitivity in peripheral tissues (Barros et al., 2008).
Adipokines [leptin (LEP; OMIM 164160), resistin (RETN; OMIM 605565), and adiponectin (ADIPOQ; OMIM 605441)], inflammatory cytokines [tumor necrosis factor-α (TNF-α; OMIM 191160), and interleukin-6 (IL-6; OMIM 147620)], and chemokines [interleukin-8 (IL-8; OMIM 146930)] have been implicated in the etiopathogenesis of insulin resistance and in the early defects of T2DM (Bastard et al., 2002, Moller, 2000, Wauters et al., 2000, Coppack, 2001, Kern et al., 2001, Steppan et al., 2001, Weyer et al., 2001, Greenberg and McDaniel, 2002, Havel, 2002, Housa et al., 2006, Kleiblová et al., 2006 and Lamounier-Zepter et al., 2008). Leptin, adiponectin and TNF-α have been suggested as much stronger predictors of pregnancy-associated insulin resistance than gestational hormones, including human placental lactogen and steroids (Lepercq et al., 1998, Kirwan et al., 2002 and Radaelli et al., 2003). In previously published studies, circulating levels of leptin, adiponectin and TNF-α in the early pregnancy closely predicted the development of GDM (Qiu et al., 2004, Hernández Valencia and Zárate, 2005, Maghbooli et al., 2007 and Gao et al., 2008).
To our best knowledge, the contribution of different fat depots (subcutaneous and visceral) to altered levels of adipokines and cytokines in GDM is unknown. Studies of patients with obesity and/or T2DM have shown that metabolic and endocrine characteristics of adipose tissue significantly vary between different locations (Wajchenberg, 2000, Coppack, 2001, Wagenknecht et al., 2003 and Dolinková et al., 2008). Placenta of patients with GDM typically displays structural and functional abnormalities (Alonso et al., 2006) suggesting possible alterations in its endocrine function including disturbed production of adipokines and/or proinflammatory factors (Masuzaki et al., 1997, Radaelli et al., 2003 and Yura et al., 2003). Previous reports confirmed that GDM elicits major changes in the expression profile of placental genes with a prominent increase in markers and mediators of inflammation (Radaelli et al., 2003).
We hypothesized that dysregulated endocrine function of adipose tissue and placenta during pregnancy may contribute to the development of insulin resistance and GDM. The aim of the present study was to characterize the changes in gene expression of adipokines [leptin, resistin, adiponectin and its receptors–adiponectin receptor 1 (ADIPOR1; OMIM 607945), and adiponectin receptor 2 (ADIPOR2; OMIM 607946)], proinflammatory cytokines (IL-6, TNF-α), chemokines (IL-8) and other receptors with potential role in the regulation of glucose and lipid homeostasis [genes for peroxisome proliferator-activated receptor-α (PPAR-α; OMIM 170998), estrogen receptor α (ESR1, ERα; OMIM 133430), and estrogen receptor β (ESR2, ERβ; OMIM 601663)] in subcutaneous and visceral adipose tissue and placenta of patients with gestational diabetes mellitus relative to those in healthy women with physiological pregnancy.
Section snippets
Study subjects
Ten women with GDM (age 34.6 ± 2.50 years) and thirteen healthy age-matched women with physiological pregnancy (age 33.1 ± 1.25 years) were included in the study. Only women with single pregnancy who delivered by planned Cesarean section in the term (40 ± 2 weeks of pregnancy) were enrolled into the study. All GDM were treated by intensive insulin therapy. All women enrolled into the study underwent the 75 g 2 h oral glucose tolerance test (oGTT) between 24th and 28th week of their pregnancy.
Anthropometric characteristic of healthy women with physiological pregnancy and pregnant women with gestational diabetes mellitus (GDM) and their newborns
The study groups were age-matched. Pregnant women with GDM had significantly higher BMI before pregnancy, higher BMI third day after delivery, and higher percentage of body fat third day after delivery relative to control group. Birth weight, birth length and birth weight/length ratio of the newborns did not differ between the groups (Table 1).
Maternal and fetal serum biochemical and hormonal parameters of GDM and control group
Maternal serum levels of adiponectin, resistin, C-peptide, triglycerides, and estradiol did not significantly differ in GDM group as compared with
Discussion
The most important finding of this study is that visceral fat leptin gene expression and subcutaneous fat IL-6 and IL-8 gene expressions were significantly increased, whereas subcutaneous fat ERα and ERβ gene expressions were significantly decreased in women with GDM relative to healthy age-matched women with physiological pregnancy.
Inspite of previously suggested predictive role for leptin in the development of GDM (Qiu et al., 2004, Maghbooli et al., 2007 and Gao et al., 2008), there is still
Acknowledgements
Supported by IGA MHCR no. 8302-5 to MH and PK. We thank to obstetricians and the patients for their collaboration. The special thank belongs to Mrs. Hana Vágnerová for help with the majority of tissue sampling.
References (63)
- et al.
Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4
Mol. Cell. Endocrinol.
(2008) - et al.
Regulation of leptin gene expression and secretion by steroid hormones
Steroids
(1999) - et al.
The endocrine profile of subcutaneous and visceral adipose tissue of obese patients
Mol. Cell. Endocrinol.
(2008) - et al.
Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice
Mol. Cell. Endocrinol.
(2008) Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes
Trends Endocrinol. Metab.
(2000)- et al.
In utero exposure to maternal obesity and diabetes: animal models that identify and characterize implications for future health
Clin. Perinatol.
(2007) - et al.
Insulin increases leptin mRNA expression in abdominal subcutaneous adipose tissue in humans
Mol. Genet. Metab.
(2000) - et al.
The ratio of estrogen receptor alpha to estrogen receptor beta in adipose tissue is associated with leptin production and obesity
Steroids
(2007) - et al.
Leptin in human pregnancy: the relationship with gestational hormones
Am. J. Obstet. Gynecol.
(1998) - et al.
Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients: no effect of apolipoprotein E polymorphism
Metabolism
(2000)
Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta
Gynecol. Endocrinol.
Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro
J. Clin. Endocrinol. Metab.
Effect of follow-up of women with gestational diabetes on the ratio of IDDM to NIDDM in pregnancy
Diab. Care
Adipokine expression profile in adipocytes of different mouse models of obesity
Horm. Metab. Res.
Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy
Am. J. Physiol. Endocrinol. Metab.
Pro-inflammatory cytokines and adipose tissue
Proc. Nutr. Soc.
Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus
Diabet. Med.
The pathophysiological influence of leptin and the tumor necrosis factor system on maternal insulin resistance: negative correlation with anthropometric parameters of neonates in gestational diabetes
Gynecol. Endocrinol.
Estrogen receptors and human disease
J. Clin. Invest.
Relative hypoleptinaemia in women with mild gestational diabetes mellitus
Diabet. Med.
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma
PLoS Genet.
Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes
Diabetes
Gestational diabetes mellitus
N. Engl. J. Med.
Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus
Chin. Med. J. (Engl).
Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes
Eur. J. Clin. Invest.
Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin
Curr. Opin. Lipidol.
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice
Proc. Natl. Acad. Sci. USA
Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1
FASEB. J.
Leptin: roles and regulation in primate pregnancy
Semin. Reprod. Med.
Recent concepts in gestational diabetes’ etiopathogenesis
Ginecol. Obstet. Mex.
Adipocytokines and cancer
Physiol. Res.
Cited by (91)
Quercetin improved histological structure and upregulated adiponectin and adiponectin receptors in the placenta of rats with gestational diabetes mellitus
2021, PlacentaCitation Excerpt :In patients with type 2 diabetes, AMPK phosphorylation is greatly reduced response to adiponectin, and this indicates that disruption of downstream signaling of the adiponectin receptors may impair the adiponectin actions or cause resistance to adiponectin [67,69]. These findings were agreement with those of Al Husseini [68], Chen [70], Kleiblova [71]. In various published studies, suggested that in GDM cases an increase the expression of these receptors may be due to reduction of adiponectin concentrations [67,72].